110 related articles for article (PubMed ID: 27466498)
21. RBPJ is a novel target for rhabdomyosarcoma therapy.
Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
[TBL] [Abstract][Full Text] [Related]
22. The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1α targeted gene expression.
Miyake K; Nishioka M; Imura S; Batmunkh E; Uto Y; Nagasawa H; Hori H; Shimada M
Exp Cell Res; 2012 Aug; 318(13):1554-63. PubMed ID: 22472348
[TBL] [Abstract][Full Text] [Related]
23. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
24. Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling.
Al-Wadei MH; Banerjee J; Al-Wadei HA; Schuller HM
Eur J Cancer; 2016 Jan; 52():188-96. PubMed ID: 26689865
[TBL] [Abstract][Full Text] [Related]
25. Conditional ablation of Notch signaling in pancreatic development.
Nakhai H; Siveke JT; Klein B; Mendoza-Torres L; Mazur PK; Algül H; Radtke F; Strobl L; Zimber-Strobl U; Schmid RM
Development; 2008 Aug; 135(16):2757-65. PubMed ID: 18635610
[TBL] [Abstract][Full Text] [Related]
26. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
27. Early pancreatic development requires the vertebrate Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex.
Masui T; Long Q; Beres TM; Magnuson MA; MacDonald RJ
Genes Dev; 2007 Oct; 21(20):2629-43. PubMed ID: 17938243
[TBL] [Abstract][Full Text] [Related]
28. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.
Büchler P; Reber HA; Büchler MW; Friess H; Lavey RS; Hines OJ
Cancer; 2004 Jan; 100(1):201-10. PubMed ID: 14692041
[TBL] [Abstract][Full Text] [Related]
29. A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.
Yamasaki A; Shoda M; Iijima H; Nagai S; Wada J; Suzuki H; Chikazawa N; Tasaka T; Kameda C; Tanaka H; Ikebe M; Jo E; Sato N; Nakamura M; Sekine F; Morisaki T; Katano M
Anticancer Res; 2009 Mar; 29(3):843-50. PubMed ID: 19414318
[TBL] [Abstract][Full Text] [Related]
30. [Regulatory mechanisms of Hedgehog signaling pathway for epithelial-mesenchymal transition in pancreatic cancer cells].
Xie K; Hao K; Tian XD; Chang ZG; Qin CF; Yang YM
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3103-6. PubMed ID: 22340649
[TBL] [Abstract][Full Text] [Related]
31. Loss of the Notch effector RBPJ promotes tumorigenesis.
Kulic I; Robertson G; Chang L; Baker JH; Lockwood WW; Mok W; Fuller M; Fournier M; Wong N; Chou V; Robinson MD; Chun HJ; Gilks B; Kempkes B; Thomson TA; Hirst M; Minchinton AI; Lam WL; Jones S; Marra M; Karsan A
J Exp Med; 2015 Jan; 212(1):37-52. PubMed ID: 25512468
[TBL] [Abstract][Full Text] [Related]
32. LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.
Niu F; Li Y; Lai FF; Ni L; Ji M; Jin J; Yang HZ; Wang C; Zhang DM; Chen XG
J Cell Physiol; 2015 Sep; 230(9):2212-23. PubMed ID: 25655308
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
[TBL] [Abstract][Full Text] [Related]
34. Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.
Feldmann G; Habbe N; Dhara S; Bisht S; Alvarez H; Fendrich V; Beaty R; Mullendore M; Karikari C; Bardeesy N; Ouellette MM; Yu W; Maitra A
Gut; 2008 Oct; 57(10):1420-30. PubMed ID: 18515410
[TBL] [Abstract][Full Text] [Related]
35. Gli2 expression and human bladder transitional carcinoma cell invasiveness.
Mechlin CW; Tanner MJ; Chen M; Buttyan R; Levin RM; Mian BM
J Urol; 2010 Jul; 184(1):344-51. PubMed ID: 20488474
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
37. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
[TBL] [Abstract][Full Text] [Related]
38. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
39. Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells.
Hu WG; Liu T; Xiong JX; Wang CY
Acta Pharmacol Sin; 2007 Aug; 28(8):1224-30. PubMed ID: 17640486
[TBL] [Abstract][Full Text] [Related]
40. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
